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LETTERS TO THE EDITOR 
Retinol Uptake by Human Keratinocytes-Receptor-Mediated or Not? 
To the Editor: 
In a recent paper Hodam et al [1] ask whether serum retinol binding 
protein (REP) delivers retinol to keratinocytes via binding to a 
cell-surface receptor as suggested by previous studies [2-5] or sim-
ply by releasing the vitamin to the aqueous milieu surrounding the 
cells. The latter possibility is supported by the facts that retinol can 
be spontaneously transferred from REP to phospholipid bilayers [6] 
and between lipid bilayers by diffusion through an aqueous phase 
[7 - 9]. Based on studies of cultured human keratinocytes, Hodam 
and co-workers conclude that REP receptors do not playa signifi-
cant role in the uptake of retinol to the cells, mainly because 1) the 
cellular uptake of [3H] retinol added directly to the culture medium 
was much faster than that of [3H]retinol-REP (Figs 1- 5); 2) [3H]re-
tinol uptake from REP was not inhibited by increasing concentra-
tions of REP saturated with unlabeled retinol (Fig 6); 3) 1251_REP 
did not bind to keratinocytes (data not shown); and 4) the dose-de-
pendent modulation of several biochemical markers of keratiniza-
tion was the same whether retinol was added directly to the culture 
or as retinol-REP (Figs 7 - 9). In the authors' opinion these results 
show that REP functions as a reservoir releasing retinol to the 
aqueous phase from where it becomes associated with the plasma 
membrane. However, several objections can be raised against the 
experimental design and the interpretation of data. First, the forma-
tion of(3H]retinol-REP did not follow standard procedures [10,11]; 
unlabeled retinol was not removed from REP prior to the addition 
of [3H]retinol and the mixture was incubated at room temperature 
overnight (possibly resulting in some denaturation of the protein). By 
this technique [3H]retinol will probably be attached either to pre-
formed apo-REP (usually representing 10% of slightly modified 
REP [12]) or to the surface of holo-REP (instead of to the specific 
binding site occupied by endogenous retinol). An equilibrium ex-
change between labeled and specifically bound, unlabeled retinol is 
precluded because the compounds were added in a 1 : 10 molar ratio 
and yet the specific activity of [3H]retinol-REP in some expenments 
indicated a 100% labeling efficiency (10.3 ,uCifnmol X 4.9 
nmol = 50 ,uCi added [3H]retinol). Two pieces of information 
about the labeled products are missing: 1) the 330/280 absorption 
ratio showing the degree of retinol saturation of REP [11], and 2) 
size exclusion gel chromatography of trace amounts of the labeled 
products mixed with an aliquot of fresh plasma showing quantita-
tively that the tracers behave identical to unlabeled REP with re-
spect to, e.g., transthyretin (TTR) binding [13]. Affinity chromatog-
raphy on TTR-Sepharose is not sufficient to re~ove dama~ed 
protein from the batch of labeled REP because el'.ltlOn by reduCl.ng 
the ionic strength may harm the labeled protem (A. Vahlqmst, 
unpublished observation). In addition, gel chromatography will 
disclose non-specific transfer of [3H]retinol to other plasma pro-
teins. Without these control experiments performed, we are not 
convinced that the labeled tracers will behave like nature holo-REP. 
Second, the incubations of keratinocytes with [3H]retinol-REP 
were performed in the absence of TTR or serum, disregarding the 
fact that TTR stabilizes the binding of retinol to REP under normal 
conditions [12]. Furthermore, the additions of [3H]retinol (1.8-
3.0 nM) and [3H]retinol-REP (18-43 nM) were normalized for 
radioactivity instead of concentration and the uptake of tracer was 
expressed in percent of applied radioactivity instead of absolute 
amounts of vitamin. Consequently, the time curves shown in Figs 
1- 3 give the false impression that free [3H]retinol is more rapidly 
taken up by the cells than [3H]retinol-REP. Compensating for the 
different specific activities of [3H]retinol and [3H]retinol-REP, the 
data in Fig 2 will show that the total amount of retinol transferred 
from REP to the cells on day 3 is about 15 times higher than that 
accomplished when retinol was added directly to the medium. Also, 
whereas the uptake of (3H]retinol added directly to the medIUm 
attained a maximum already after 2-3 h, the delivery of [3H]re-
tinol-REP was linear over time for several days, consistent with a 
receptor mechanism operating at non-saturating conditions (note: 
the retinol concentrations were 1/100 to 1/1000 those in vivo). 
Incidently, the authors' notion that "[3H]retinol added to the tissue 
culture medium exists in at least two distinct physical states" implies 
that free retinol was adsorbed to the plastic walls or extensively 
degraded during incubation, which could easily have been checked 
by high-performance liquid chromatography analysis of the radioac-
tive compounds remaining in the medium. 
Third, an equipotency of free retinol and holo-REP as modifiers 
of keratinocyte function does not prove that retinol enters the cel~s 
via the aqueous phase under physiologic conditions. To be biologI-
cally active retinol must be metabolized to retinoic acid and then 
bound to the nuclear receptors that modify gene expression. Bio-
logic effects, such as expression of protein synthesis, will therefore 
take several hours or even days before being noticeable. AccordIng 
to the authors' own hypothesis, retinol added directly to the me-
dium should be internalized more rapidly than retinol-REP and 
thus initiate a quicker and more sustained biologic response. Yet, 
retinol was no more effective than holo-REP in experiments termi-
nated after 34 h. The findings of Hod am and co-workers are also at 
variance with preliminary results showing that the retinol-~P 
complex is at least 10 times more potent than free retinol in inhibIt-
ing terminal differentiation of primary human keratinocytes grown 
in vitro (measured as keratin Kl expression, c.-O. Biivik and U. 
Eriksson, personal communication). 
Interestingly, Biivik et al [14] recently characterized a REP recep-
tor from retinal pigment epithelium, the isolation of which will 
allow a proper elucidation of the receptor mechanism (C.-O. Biivlk 
and U. Eriksson, personal communication). It will then be interest-
ing to see if pre-incubation of REP with high amounts of unlabeled ' 
retinol, as performed by Hodam et al [1], adversely affects its bind~ 
ing to the receptor, thus explaining the lack of competition with 
[3H]retinol-REP uptake (Fig 6). 
In conclusion, we feel that the paper by Hodam and co-workers 
provides no firm basis to rule out REP receptors as important media-
tors of retinol uptake to keratinocytes under physiologic condition. 
We agree, however, that retinol may also enter the cells via the 
aqueous phase and that this is the predominating route in conditio~s 
of hypervitaminosis A and during oral treatment with synthet~c 
retinoids. Irrespective of its way of entering keratinocytes, retinol IS 
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REPLY 
We read with interest the letter from Drs. Vahlquist and Torma 
concerning our recent paper by Hodam et al [1] and are happy to 
respond to the criticisms they raised about our work and the conclu-
sions we drew from the data. In fact, we are pleased that our work 
has generated a constructive dialogue on the controversial topic of 
whether or not cells express a cell-surface receptor for serum re-
tinol-binding protein (RBP) that mediates the delivery of retinol 
from RBP to the cell. It is now well over 15 years since it was first 
reported that retinal pigment epithelial (RPE) cells contain RBP 
receptors [2]; however, to date no RBP receptor has been purified 
and its biochemical properties characterized. In fact, we believe that 
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it has been very unfortunate that, despite the lack of solid evidence 
for RBP receptors, it is repeatedly implied in the literature that 
cell-surface RBP receptors are important for the uptake of retinol 
from RBP. Therefore, we felt that a careful re-examination of this 
issue of RBP receptors and retinol delivery was certainly warranted 
and believed that cultured keratinocytes, a cell type that responds to 
retinoids, would provide an ideal model system for these studies. 
Thus, about 7 years ago we initiated studies using cultured mouse 
keratinocytes to determine if retinol delivery from RBP to these 
cells involved RBP receptors. In our initial study published in the 
]ID [3] we reported that mouse keratinocytes failed to exhibit high-
affinity receptors for RBP. In the recent paper by Hodam et al [1], 
we used cultured human keratinocytes (HKc) and concluded that 
HKc do not express RBP receptors and that retinol is released from 
RBP into the aqueous phase prior to becoming cell-associated. 
These conclusions are in fact consistent with recent reports that 
demonstrate that retinol is spontaneously and rapidly released from 
RBP [4] and that retinol is transferred from RBP to lipid vesicles [5]. 
We believe that a point by point response to the comments made by 
Vahlquist and Torma is appropriate and will demonstrate that the 
experimental design used in our studies and the conclusions drawn 
from the results are scientifically sound. 
First, the procedures used for the formation and isolation of the 
[3H]retinol-RBP complex used in these studies was questioned. Al-
though, it is not clear to us what is meant by "standard procedures," 
we feel that adding [3H]retinol back to apoRBP generated during 
RBP purification is preferable to adding [3H]retinol to apoRBP 
generated by solvent extraction. Clearly, there is more of a chance 
of generating denatured RBP by exposure to solvent rather than, as 
suggested, from the overnight incubation we used. We are surprised 
that Dr. Vahlquist would question the use of affinity chromatogra-
phy on transthyretin (TTR)-Sepharose as a means for purifying the 
[3H]retinol-RBP complex because it was his procedure we followed 
[6]. Although it is extremely difficult to demonstrate conclusively 
that the site on RBP we labeled with [3H]retinol is identical to that 
labeled in vivo, we have taken great pains to characterize the [3H]re-
tinol-RBP complex and are convinced that it behaves like in vivo 
holoRBP. We have demonstrated by sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and by high-per-
formance liquid chromatography (HPLC) that we have purified 
RBP to homogeneity, thus eliminating the possibility that we are 
labeling other plasma proteins in vitro with [3H]retinol ([3] and 
unpublished results). In addition, we have shown that the [3H]re-
tinol-RBP complex co-chromatographs with unlabeled holoRBP 
on a Mono Q HR5/5 column and have also shown by HPLC that 
100% of the label associated with our RBP chromatographs as all-
trans-retinol [3]. Finally, the [3H]retinol-RBP complex binds to 
immobilized TTR. The "labeling efficiency" of the RBP with 
[3H]retinol was also questioned. Indeed, in some experiments al-
most 100% of the added pH]retinol was recovered bound to the 
RBP. This was, however, not unexpected and, in fact, the incuba-
tion conditions were designed with this intention in mind. Our 
purified RBP preparations exhibited a 330/280 absorption ratio of 
0.56 ± 0.13 indicating about 44% of the RBP was in the apo-form. 
Because our in vitro incubations contained 100 J1.g of RBP (there-
fore about 2 nmol of apo-RBP) and 50 J1.Ci of [3H]retinol (1 nmol) 
there was ample apoRBP to bind all of the added [3H]retinol. 
The second point raised by Vahlquist and Torma regarded the 
fact that our uptake experiments were conducted with [3H]retinol-
RBP complex rather than [3H]retinol-RBP-TTR. We have 
previously shown that TTR has little to no influence on the uptake 
of [3H]retinol from RBP (Table II in [3]). In addition, other reports, 
even those supporting a cell-surface receptor for RBP, have con-
cluded that TTR does not playa role in the interaction between 
RBP and the putative RBP receptor [2,7,8] . The next point of ques-
tion concerned the differences in the concentrations of free [3H]re-
tinol and [3H]retinol-RBP used in the time course of [3H]retinol 
uptake experiments presented in Figs 1 and 2 (this does not apply to 
Fig 3) and whether the expression of the uptake data as the percent 
